Skip to main content
Erschienen in: Annals of Surgical Oncology 8/2005

01.08.2005

Surgical Resection of Primary Tumors in Patients Who Present With Stage IV Colorectal Cancer: An Analysis of Surveillance, Epidemiology, and End Results Data, 1988 to 2000

verfasst von: Alan D. Cook, MD, Richard Single, PhD, Laurence E. McCahill, MD, FACS

Erschienen in: Annals of Surgical Oncology | Ausgabe 8/2005

Einloggen, um Zugang zu erhalten

Abstract

Background

Surgical resection of the primary tumor for patients who present with incurable stage IV colorectal cancer is controversial. National practice patterns have not been described. We evaluated the use of primary tumor resection in patients presenting with stage IV colorectal cancer.

Methods

Patients with stage IV colorectal cancer diagnosed between 1988 and 2000 were selected from the Surveillance, Epidemiology, and End Results database. Patients undergoing primary tumor resection were analyzed on the basis of sex, race, year of diagnosis, and the anatomical site of the primary tumor. We compared the survival of resected and nonresected patients.

Results

A total of 17,658 (66%) of the 26,754 patients presenting with stage IV colorectal cancer underwent primary tumor resection. Patients with resected disease were more likely to be young (mean age of 67.1 vs. 70.3 years) and to have right-sided tumors (75.3%, 73.0%, and 45.6%, respectively, for right, left, and rectal; P < .001). In all age groups, patients undergoing resection had higher median and 1-year survival rates (colon: 11 vs. 2 months, 45% vs. 12%, P < .001; rectum: 16 vs. 6 months, 59% vs. 25%, P < .001) when compared with patients who did not undergo resection.

Conclusions

Most patients who present with stage IV colorectal cancer undergo resection of the primary tumor. The proportion of patients undergoing resection depends on patient age and race and the anatomical location of the primary tumor. The degree to which case selection explains the treatment and survival differences observed is not known. Further investigation of the role of surgery in the management of incurable stage IV colorectal cancer is warranted.
Literatur
1.
Zurück zum Zitat American Cancer Society, Cancer Facts and Figures 2002. Available: http://www.cancer.org/docroot American Cancer Society, Cancer Facts and Figures 2002. Available: http://​www.​cancer.​org/​docroot
2.
Zurück zum Zitat Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis J Am Coll Surg 2003;197:233–42 Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis J Am Coll Surg 2003;197:233–42
3.
Zurück zum Zitat Sarela AI, Gutherie JA, Seymour MT, Ride E, Guillou PJ, O’Riordain DS. Non-operative management of the primary tumor in patients with incurable stage IV colorectal cancer Br J Surg 2001;88:1352–6 Sarela AI, Gutherie JA, Seymour MT, Ride E, Guillou PJ, O’Riordain DS. Non-operative management of the primary tumor in patients with incurable stage IV colorectal cancer Br J Surg 2001;88:1352–6
4.
Zurück zum Zitat Rosen SA, Buell JF, Yoshida A, et al. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 2000;135:530–4 Rosen SA, Buell JF, Yoshida A, et al. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 2000;135:530–4
5.
Zurück zum Zitat Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients J Am Coll Surg 2003;196:722–8 Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients J Am Coll Surg 2003;196:722–8
6.
Zurück zum Zitat Longo WE, Virgo KS, Johnson FE, et al. Risk factors for morbidity and mortality after colectomy for colon cancer Dis Colon Rectum 2000;43:83–91 Longo WE, Virgo KS, Johnson FE, et al. Risk factors for morbidity and mortality after colectomy for colon cancer Dis Colon Rectum 2000;43:83–91
7.
Zurück zum Zitat Makela J, Haukipuro K, Laitinen S, Kairaluoma MI. Palliative operations for colorectal cancer Dis Colon Rectum 1990;33:846–50 Makela J, Haukipuro K, Laitinen S, Kairaluoma MI. Palliative operations for colorectal cancer Dis Colon Rectum 1990;33:846–50
8.
Zurück zum Zitat Legendre H, Vanhuyse F, Caroli-Bosc FX, Pector JC. Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction Eur J Surg Oncol 2001;27:364–7 Legendre H, Vanhuyse F, Caroli-Bosc FX, Pector JC. Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction Eur J Surg Oncol 2001;27:364–7
9.
Zurück zum Zitat Tebbutt NC, Norman AR, Cunningham D, et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases Gut 2003;52:568–73 Tebbutt NC, Norman AR, Cunningham D, et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases Gut 2003;52:568–73
10.
Zurück zum Zitat Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease Ann Surg Oncol 1999;6:651–7 Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease Ann Surg Oncol 1999;6:651–7
11.
Zurück zum Zitat Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population Med Care 2002;40(8 Suppl):IV-3–18 Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population Med Care 2002;40(8 Suppl):IV-3–18
12.
Zurück zum Zitat SEER Cancer Statistics Review 2000. National Cancer Institute, Bethesda, MD: U.S. Department of Health and Human Services, 2003 SEER Cancer Statistics Review 2000. National Cancer Institute, Bethesda, MD: U.S. Department of Health and Human Services, 2003
13.
Zurück zum Zitat Yancik R, Havlik RJ, Wesley MN, et al. Cancer and comorbidity in older patients: a descriptive profile Ann Epidemiol 1996;6:399–412 Yancik R, Havlik RJ, Wesley MN, et al. Cancer and comorbidity in older patients: a descriptive profile Ann Epidemiol 1996;6:399–412
14.
Zurück zum Zitat Surveillance, Epidemiology, and End Results. SEER Cancer Statistics Review. Bethesda: National Cancer Institute, 2000 Surveillance, Epidemiology, and End Results. SEER Cancer Statistics Review. Bethesda: National Cancer Institute, 2000
15.
Zurück zum Zitat Khot UP, Lang WA, Murali K, Parker MC. Systematic review of the efficacy and safety of colorectal stents Br J Surg 2002;89:1096–102 Khot UP, Lang WA, Murali K, Parker MC. Systematic review of the efficacy and safety of colorectal stents Br J Surg 2002;89:1096–102
16.
Zurück zum Zitat Greene FL, Balch C, Page DL, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag, 2002 Greene FL, Balch C, Page DL, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag, 2002
17.
Zurück zum Zitat Agresti A. Categorical Data Analysis. New York: Wiley, 1990 Agresti A. Categorical Data Analysis. New York: Wiley, 1990
18.
Zurück zum Zitat Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer N Engl J Med 2001;345:1655–9 Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer N Engl J Med 2001;345:1655–9
19.
Zurück zum Zitat vanDerBurg ME, Van Lent M, Buyse M, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advance epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer N Engl J Med 1995;332:629–34 vanDerBurg ME, Van Lent M, Buyse M, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advance epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer N Engl J Med 1995;332:629–34
20.
Zurück zum Zitat Ellis H. Curative and palliative surgery in advanced carcinoma of the large bowel Br Med J 1971;3:291–3 Ellis H. Curative and palliative surgery in advanced carcinoma of the large bowel Br Med J 1971;3:291–3
21.
Zurück zum Zitat Isbister WH. Audit of definitive colorectal surgery in patients with early and advanced colorectal cancer Aust N Z J Surg 2001;72:271–4 Isbister WH. Audit of definitive colorectal surgery in patients with early and advanced colorectal cancer Aust N Z J Surg 2001;72:271–4
22.
Zurück zum Zitat Joffe J, Gordon PH. Palliative resection for colorectal carcinoma Dis Colon Rectum 1981;24:355–60 Joffe J, Gordon PH. Palliative resection for colorectal carcinoma Dis Colon Rectum 1981;24:355–60
23.
Zurück zum Zitat Dunn GP. Surgical palliation in advanced disease: recent developments Curr Oncol Rep 2002;4:233–41 Dunn GP. Surgical palliation in advanced disease: recent developments Curr Oncol Rep 2002;4:233–41
24.
Zurück zum Zitat Palliative Care Task Force. Report to the field. J Am Coll Surg 2003;197:661–86 Palliative Care Task Force. Report to the field. J Am Coll Surg 2003;197:661–86
25.
Zurück zum Zitat Kim JP, Kim SJ, Lee JH, Kim SW, Choi MG, Yu HJ. Surgery in the aged in Korea Arch Surg 1998;133:18–23 Kim JP, Kim SJ, Lee JH, Kim SW, Choi MG, Yu HJ. Surgery in the aged in Korea Arch Surg 1998;133:18–23
26.
Zurück zum Zitat Burns-Cox N, Campbell WB, van Nimmen BAJ, Vercaeren PMK, Lucarotti M. Surgical care and outcomes for patients in their nineties Br J Surg 1996;84:496–8 Burns-Cox N, Campbell WB, van Nimmen BAJ, Vercaeren PMK, Lucarotti M. Surgical care and outcomes for patients in their nineties Br J Surg 1996;84:496–8
27.
Zurück zum Zitat El-Haddawi F, Abu-Zidan FM, Jones W. Factors affecting surgical outcome in the elderly at Auckland Hospital Aust N Z J Surg 2002;72:537–41 El-Haddawi F, Abu-Zidan FM, Jones W. Factors affecting surgical outcome in the elderly at Auckland Hospital Aust N Z J Surg 2002;72:537–41
28.
Zurück zum Zitat Spivak H, Maele DV, Friedman I, Nussbaum M. Colorectal surgery in octogenarians J Am Coll Surg 1996;183:46–50 Spivak H, Maele DV, Friedman I, Nussbaum M. Colorectal surgery in octogenarians J Am Coll Surg 1996;183:46–50
29.
Zurück zum Zitat Bader TF. Colorectal cancer in patients older than 75 years of age Dis Colon Rectum 1986;29:728–32 Bader TF. Colorectal cancer in patients older than 75 years of age Dis Colon Rectum 1986;29:728–32
30.
Zurück zum Zitat Keller SM, Markovitz LJ, Wilder JR Jr, Aufses AH. Emergency and elective surgery in patients over age 70 Am Surg 1987;53:636–40 Keller SM, Markovitz LJ, Wilder JR Jr, Aufses AH. Emergency and elective surgery in patients over age 70 Am Surg 1987;53:636–40
31.
Zurück zum Zitat Colorectal Cancer Collaborative Group. Surgery for colorectal cancer in elderly patients: a systematic review. Lancet 2000;356:968–74 Colorectal Cancer Collaborative Group. Surgery for colorectal cancer in elderly patients: a systematic review. Lancet 2000;356:968–74
32.
Zurück zum Zitat Yancik R, Wesley MN, Ries L, et al. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study Cancer 1998;82:2123–34 Yancik R, Wesley MN, Ries L, et al. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study Cancer 1998;82:2123–34
33.
Zurück zum Zitat Richards RJ, Reker DM. Racial differences in use of colonoscopy, sigmoidoscopy, and barium enema in Medicare beneficiaries Dig Dis Sci 2002;47:2715–9 Richards RJ, Reker DM. Racial differences in use of colonoscopy, sigmoidoscopy, and barium enema in Medicare beneficiaries Dig Dis Sci 2002;47:2715–9
34.
Zurück zum Zitat Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival J Natl Cancer Inst 1995;87:1686–93 Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival J Natl Cancer Inst 1995;87:1686–93
35.
Zurück zum Zitat Cooper GS, Yuan Z, Landefeld CS, Rimm AA. Surgery for colorectal cancer: race-related differences in rates and survival among Medicare beneficiaries Am J Public Health 1996;86:582–6 Cooper GS, Yuan Z, Landefeld CS, Rimm AA. Surgery for colorectal cancer: race-related differences in rates and survival among Medicare beneficiaries Am J Public Health 1996;86:582–6
36.
Zurück zum Zitat Dominitz JA, Samsa GP, Landsman P, Provenzale D. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system Cancer 1998;82:2312–20 Dominitz JA, Samsa GP, Landsman P, Provenzale D. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system Cancer 1998;82:2312–20
37.
Zurück zum Zitat Rabeneck L, Souchek J, El-Serag HB. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System Am J Gastroenterol 2003;98:1186–92 Rabeneck L, Souchek J, El-Serag HB. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System Am J Gastroenterol 2003;98:1186–92
38.
Zurück zum Zitat Mandelblatt JS, Yabroff KR, Kerner JF. Equitable access to cancer services: a review of barriers to quality care Cancer 1999;86:2378–90 Mandelblatt JS, Yabroff KR, Kerner JF. Equitable access to cancer services: a review of barriers to quality care Cancer 1999;86:2378–90
39.
Zurück zum Zitat Wudel LJ, Chapman WC, Shyr Y, et al. Disparate outcomes in patients with colorectal cancer Arch Surg 2002;137:550–6 Wudel LJ, Chapman WC, Shyr Y, et al. Disparate outcomes in patients with colorectal cancer Arch Surg 2002;137:550–6
40.
Zurück zum Zitat Rodel C, Grabenbauer GG, Papadopoulos T, Hohenberger W, Schmoll HJ, Sauer R. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer J Clin Oncol 2003;21:3098–104 Rodel C, Grabenbauer GG, Papadopoulos T, Hohenberger W, Schmoll HJ, Sauer R. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer J Clin Oncol 2003;21:3098–104
41.
Zurück zum Zitat Banerjee AK. Sexual dysfunction after surgery for rectal cancer Lancet 1999;353:1900–2 Banerjee AK. Sexual dysfunction after surgery for rectal cancer Lancet 1999;353:1900–2
42.
Zurück zum Zitat Baron TH. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract N Engl J Med 2001;344:1681–7 Baron TH. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract N Engl J Med 2001;344:1681–7
43.
Zurück zum Zitat Kim CJ, Yeatman TJ, Coppola D, et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation Ann Surg 2001;234:352–8; discussion 358–9 Kim CJ, Yeatman TJ, Coppola D, et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation Ann Surg 2001;234:352–8; discussion 358–9
44.
Zurück zum Zitat Repici A, Reggio D, De Angelis C, et al. Covered metal stents for management of inoperable malignant colorectal strictures Gastrointest Endosc 2000;52:735–40 Repici A, Reggio D, De Angelis C, et al. Covered metal stents for management of inoperable malignant colorectal strictures Gastrointest Endosc 2000;52:735–40
45.
Zurück zum Zitat Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic cancer N Engl J Med 2000;343:905–14 Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic cancer N Engl J Med 2000;343:905–14
46.
Zurück zum Zitat deGramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 2000;18:2938–47 deGramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 2000;18:2938–47
47.
Zurück zum Zitat Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 2004;350:2335–42 Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 2004;350:2335–42
Metadaten
Titel
Surgical Resection of Primary Tumors in Patients Who Present With Stage IV Colorectal Cancer: An Analysis of Surveillance, Epidemiology, and End Results Data, 1988 to 2000
verfasst von
Alan D. Cook, MD
Richard Single, PhD
Laurence E. McCahill, MD, FACS
Publikationsdatum
01.08.2005
Erschienen in
Annals of Surgical Oncology / Ausgabe 8/2005
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/ASO.2005.06.012

Weitere Artikel der Ausgabe 8/2005

Annals of Surgical Oncology 8/2005 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.